HealthMatch secures $1.3M for US expansion
HealthMatch, an Australian start-up aiming to become the go-to platform linking sick patients with clinical trials of potential treatment, is targeting US expansion after a $1.3 million capital raising from Australian venture capital and US industry insiders.
The company has created an online platform which uses machine learning to sort through the thousands of clinical trials being run by contract research organisations (CROs) in Australia and matches relevant registered patients. Its cofounders Manuri Gunawardena and Arran Schlosberg needed funding to hire software engineers and some marketing and operations staff as the company starts to grow in earnest.
The funding round was led by Sydney-based venture capital fund Tempus Partners, which closed a $40 million fund to invest in local start-ups last year. The round also included backing from US-based investors including WhatsApp head of product Anton Borzov, and Google’s director of intellectual property and litigation Catherine Lacavera.